Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl-Uwe Petersen

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Drugs in R&D|October 20, 2021
Comment on: "Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS"Karl-Uwe Petersen
MMW Fortschritte Der Medizin|January 24, 2012
[Basic drugs in pain therapy under discussion. How safe is paracetamol? (interview by Dr. Judith Neumaier)]Karl-Uwe Petersen
Medizinische Monatsschrift Fur Pharmazeuten|August 23, 2011
[Evaluation of pharmacokinetic drug-drug-interactions. Critical considerations of the relevance of pharmacokinetic drug-drug interactions of proton pump inhibitors in self medication]Karl-Uwe Petersen
Arzneimittel-Forschung|March 1, 2003
In vitro release of felodipine from original brand and generic productsKarl-Uwe Petersen
MMW Fortschritte Der Medizin|July 3, 2016
[Not Available]Karl-Uwe Petersen
Medizinische Monatsschrift Fur Pharmazeuten|September 15, 2015
[Options in the treatment of hepatic encephalopathy]Karl-Uwe Petersen
Digestive Diseases (Basel, Switzerland)|October 6, 2017
Pepsin and Its Importance for Functional Dyspepsia: Relic, Regulator or Remedy?Karl-Uwe Petersen
Arzneimittel-Forschung|February 26, 2004
Complementary mode of action of rosiglitazone and metformin in a single tablet for the treatment of diabetes mellitus type 2Karl-Uwe Petersen
MMW Fortschritte Der Medizin|June 10, 2014
[Caffeine in analgesics--myth or medicine?]Karl-Uwe Petersen
Arzneimittel-Forschung|June 23, 2009
Relevance of metabolic activation pathways: the example of clopidogrel and prasugrelKarl-Uwe Petersen
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Drugs in R&D|October 20, 2021
Comment on: "Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS"Karl-Uwe Petersen
MMW Fortschritte Der Medizin|January 24, 2012
[Basic drugs in pain therapy under discussion. How safe is paracetamol? (interview by Dr. Judith Neumaier)]Karl-Uwe Petersen
Medizinische Monatsschrift Fur Pharmazeuten|August 23, 2011
[Evaluation of pharmacokinetic drug-drug-interactions. Critical considerations of the relevance of pharmacokinetic drug-drug interactions of proton pump inhibitors in self medication]Karl-Uwe Petersen
Arzneimittel-Forschung|March 1, 2003
In vitro release of felodipine from original brand and generic productsKarl-Uwe Petersen
MMW Fortschritte Der Medizin|July 3, 2016
[Not Available]Karl-Uwe Petersen
Medizinische Monatsschrift Fur Pharmazeuten|September 15, 2015
[Options in the treatment of hepatic encephalopathy]Karl-Uwe Petersen
Digestive Diseases (Basel, Switzerland)|October 6, 2017
Pepsin and Its Importance for Functional Dyspepsia: Relic, Regulator or Remedy?Karl-Uwe Petersen
Arzneimittel-Forschung|February 26, 2004
Complementary mode of action of rosiglitazone and metformin in a single tablet for the treatment of diabetes mellitus type 2Karl-Uwe Petersen
MMW Fortschritte Der Medizin|June 10, 2014
[Caffeine in analgesics--myth or medicine?]Karl-Uwe Petersen
Arzneimittel-Forschung|June 23, 2009
Relevance of metabolic activation pathways: the example of clopidogrel and prasugrelKarl-Uwe Petersen
Pageof 4